# A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression

> **NCT07396272** · PHASE2 · RECRUITING · sponsor: **Daniel Lindqvist** · enrollment: 12 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **DRUG:** Treatment with Ketamine Hydrochloride Prolonged-Release Tablets

## Key facts

- **NCT ID:** NCT07396272
- **Lead sponsor:** Daniel Lindqvist
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396272, "A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07396272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*